Summary
The anticonvulsant activities of both carbamazepine and diphenylhydantoin alone (after a single intraperitoneal administration) or combined with aminophylline were studied against maximal electroshock-induced convulsions in male mice. Aminophylline (injected acutely at 50 mg/kg) significantly increased the ED50 values of both antiepileptics. Given for three days, aminophylline (50 mg/kg, twice daily) still impaired the potency of both antiepileptics and after chronic aminophylline administration a further decrease in the protective activity of carbamazepine and diphenylhydantoin was found. Specifically, after 14 days of aminophylline treatment, ED50s for carbamazepine and diphenylhydantoin were 26 and 19 mg/kg, respectively. These ED50s were significantly elevated compared to values determined after acute aminophylline treatment (21.2 and 14.9 mg/kg, respectively). Plasma levels of both antiepileptics were unaffected by chronic aminophylline which seems to exclude a pharmacokinetic interaction in terms of total plasma levels at least.
The present results clearly indicate that the aminophylline-induced impairment of the anticonvulsant activity of carbamazepine and diphenylhydantoin is enhanced over time. This may render aminophylline a hazardous drug to epileptic patients who are prescribed this smooth muscle relaxant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ault B, Olney MA, Joyner LJ, Boyer CE, Notrica MA, Soroko FE, Wang CM (1987) Proconvulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy. Brain Res 426: 93–102
Chu N-S (1981) Caffeine- and aminophylline-induced seizures. Epilepsia 22: 85–94
Czuczwar SJ, Turski WA, Ikonomidou C, Turski L (1985) Aminophylline and CGS8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 26: 693–696
Czuczwar SJ, Kleinrok Z (1990) Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients. Pharmacol Res 22: 661–665
Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski WA (1986) Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27: 204–208
Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z (1987 a) Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol 144: 309–315
Czuczwar SJ, Jäckel R, Löscher W (1987 b) Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res 1: 234–238
Czuczwar SJ, Kleinrok Z, Turski L, Turski WA (1987 c) Effect of aminophylline and enprofylline on the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28: 383–386
Czuczwar SJ, Turski L, Ikonomidou C, Turski WA, Kleinrok Z (1987 d) Purinergic component in the action of common antiepileptic drugs? In: Wolf P, Dam M, Janz M, Dreifuss FE (eds) Advances in epileptology. Raven Press, New York, pp 511–513
Czuczwar SJ, Janusz W, Szczepanik B, Wamil A, Kleinrok Z (1989) Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci Res 6: 470–474
Czuczwar SJ, Gasior M, Janusz W, Szczepanik B, Wlodarczyk D, Kleinrok Z (1990 a) Influence of different methylxanthines upon the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia 31: 318–323
Czuczwar SJ, Szczepanik B, Wamil A, Janusz W, Kleinrok Z (1990 b) Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice. J Neural Transm 81: 153–166
Czuczwar SJ, Janusz W, Szczepanik B, Kleinrok Z (1991) Influence of CGS 15943 A (a non-xanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. J Neural Transm 86: 127–134
Dragunow WM, Goddard GV, Laverty R (1985) Is adenosine an endogenous anticonvulsant? Epilepsia 26: 480–487
Finn IB, Holtzmann SG (1986) Tolerance to caffeine-induced stimulation of locomotor activity in rats. J Pharmacol Exp Ther 238: 542–546
Hirsh K (1984) Central nervous system pharmacology of the dietary methylxanthines. In: Spiller GA (ed) The methylxanthines beverages and foods: chemistry, consumption and health effects. Alan R Liss, New York, pp 235–301
Laursen LC, Johanesson N, Sondergaard I, Weeke B (1984) Comparison of oral enprofylline and theophylline in asthmatic patients. Eur J Clin Pharmacol 26: 707–709
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
Mally J, Connick JH, Stone TW (1990) Theophylline down-regulates adenosine receptor function. Brain Res 509: 141–144
Murray TF (1982) Upregulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol 82: 113–114
Persson CGA, Kjellin G (1981) Enprofylline, a principally new antiasthmatic xanthine. Acta Pharmacol Toxicol 49: 313–316
Phillis JW (1984) Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia 25: 765–772
Reddington M, Lee KS, Schubert P (1982) An A1-adenosine receptor characterized by (3H)cycloheksyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation. Neurosci Lett 28: 275–279
Schwabe U, Ukena D, Lohse MJ (1985) Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedebergs Arch Pharmacol 330: 212–221
Skerrit JH, Davies P, Johnson GAR (1983 a) Interaction of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies. Epilepsia 24: 492–498
Skerrit JH, Johnston GAR, Chen Chow S (1983 b) Interaction of the anticonvulsant carbamazepine with adenosine receptors. 2. Pharmacological studies. Epilepsia 24: 643–650
Swinyard EA, Brown WC, Goddman LS (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106: 319–330
Ukena, Sybrecht (1990) Management of chronic airway obstruction: theophylline — is it still necessary? Lung [Suppl]: 127–134
Van Calker D, Steber R, Klotz K-N, Greil W (1991) Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur J Pharmacol — Mol Pharmacol Sect 206: 285–290
Weir RL, Padgett W, Daly JW, Anderson SM (1984) Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia 25: 492–498
Yarnell PR, Chu N-S (1975) Focal seizures and aminophylline. Neurology 25: 819–822
Zwillich CW, Sutton FD, Neff TA, Cohn WM, Matthay RA, Weinberger MM (1975) Theophylline-induced seizures in adults. Ann Intern Med 82: 784–787
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wlaź, P., Roliński, Z., Kleinrok, Z. et al. Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J. Neural Transmission 89, 41–48 (1992). https://doi.org/10.1007/BF01245350
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245350